Ma et al. first identified the presence of 1.3% to 13.6% of CD133+ cells in 35 individual HCC specimens by flow cytometry that generated tumors in SCID/Beige mice in serial transplantations [7]. This evidence concerns the gene PROM1 and hepatocellular carcinoma.